I agree that this site is using cookies. You can find further informations here.
X
Weisel, K
427  results:
Search for persons X
?
1

Increased incidence of immune thrombocytopenia (ITP) in 202..:

Schaefers, C. ; Paulsen, F.‐O. ; Frenzel, C....
British Journal of Haematology.  201 (2023)  2 - p. 222-226 , 2023
Link: https://doi.org/10.1111/..
 
?
2

P18 Adjusted Comparison of Teclistamab Versus Real-World Ph..:

Mateos, M.V. ; Chari, A. ; Usmani, S.Z....
Value in Health.  26 (2023)  12 - p. S5 , 2023
Link: https://doi.org/10.1016/..
 
?
3

P09 DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE (D-RD) ..:

Weisel, K. ; Kumar, S. ; Moreau, P....
HemaSphere.  7 (2023)  S2 - p. 14-15 , 2023
Link: https://doi.org/10.1097/..
 
?
4

P16 HEALTH-RELATED QUALITY OF LIFE FOR FRAIL TRANSPLANT-INE..:

Facon, T. ; Plesner, T. ; Usmani, S....
HemaSphere.  7 (2023)  S2 - p. 18-19 , 2023
Link: https://doi.org/10.1097/..
 
?
5

P958: REAL-LIFE CURRENT STANDARD OF CARE IN PATIENTS WITH R..:

Einsele, H. ; Moreau, P. ; De Stefano, V....
HemaSphere.  6 (2022)  - p. 848-849 , 2022
Link: https://doi.org/10.1097/..
 
?
6

P901: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE IN LENALI..:

Oriol, A. ; Dimopoulos, M. ; Schjesvold, F....
HemaSphere.  6 (2022)  - p. 792-793 , 2022
Link: https://doi.org/10.1097/..
 
?
7

P942: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS ..:

Usmani, S. Z. ; Mielnik, M. ; Koh, Y....
HemaSphere.  6 (2022)  - p. 832-833 , 2022
Link: https://doi.org/10.1097/..
 
?
8

P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TE..:

Einsele, H. ; Moreau, P. ; Delforge, M....
HemaSphere.  6 (2022)  - p. 825-826 , 2022
Link: https://doi.org/10.1097/..
 
?
9

P960: HEALTH-RELATED QUALITY OF LIFE IN THE LOCOMMOTION STU..:

Delforge, M. ; Moreau, P. ; Einsele, H....
HemaSphere.  6 (2022)  - p. 850-851 , 2022
Link: https://doi.org/10.1097/..
 
?
10

P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D-RD IN REL..:

Spencer, A. ; Moreau, P. ; Mateos, M.-V....
HemaSphere.  6 (2022)  - p. 823-824 , 2022
Link: https://doi.org/10.1097/..
 
?
11

P1739: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TRIP..:

van de Donk, N. W. ; Guo, S. ; Shi, L....
HemaSphere.  6 (2022)  - p. 1620-1621 , 2022
Link: https://doi.org/10.1097/..
 
?
12

P936: TIME TO RESPONSE, DURATION OF RESPONSE, AND PATIENT-R..:

Facon, T. ; Kumar, S. K. ; Plesner, T....
HemaSphere.  6 (2022)  - p. 826-827 , 2022
Link: https://doi.org/10.1097/..
 
?
13

P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY ..:

Hillengass, J. ; Cohen, A. D. ; Delforge, M....
HemaSphere.  6 (2022)  - p. 849-850 , 2022
Link: https://doi.org/10.1097/..
 
?
14

P890: THE OUTCOME OF SECOND PRIMARY MALIGNANCIES DEVELOPING..:

Avivi, I. ; H vesole, D. ; Dávila Valls, J....
HemaSphere.  6 (2022)  - p. 782-783 , 2022
Link: https://doi.org/10.1097/..
 
?
15

P973: REAL-WORLD STUDY ON ADOPTION OF STANDARD OF CARE (SOC..:

Weisel, K. ; Wadlund, A. ; Gungor, G....
HemaSphere.  6 (2022)  - p. 863-864 , 2022
Link: https://doi.org/10.1097/..
 
1-15